TrialAntimicrobial agents and chemotherapy2026

Safety and pharmacokinetics of CL-197, a potent compound with low cytotoxicity against HIV-1: a randomized, double-blind, placebo-controlled, first-in-human phase 1 clinical trial.

Yuming Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.